Ceftolozane + Tazobactam brands and prices in Pakistan
Follow price changesCeftolozane + Tazobactam · ATC J01DI · Anti-infectives · Third-generation cephalosporins
Ceftolozane + Tazobactam brands in Pakistan
One brand of Ceftolozane + Tazobactam is registered in Pakistan, from 1 company, in 2 presentations (strength, form and pack size). The most common are 1 g + 0.5 g infusion (1 brand) and 1 g + 0.5 g injection (1 brand). For Ceftolozane + Tazobactam 1 g + 0.5 g infusion, the lowest official price is PKR 16,947 per unit (Zerbaxa by Searle Pakistan Limited). Prices are the official maximum retail prices in DRAP records. Brands with the same strength and form contain the same medicine; ask your doctor or pharmacist before you switch brands.
Ceftolozane + Tazobactam price in Pakistan by strength and form
| Strength and form | Brands | Lowest price | Median price | Highest price |
|---|---|---|---|---|
| 1 g + 0.5 g infusion | 1 | PKR 16,947 / unitZerbaxa | — | — |
| 1 g + 0.5 g injection | 1 | PKR 16,948 / vialZerbaxa | — | — |
Choose a form
Available brands
One brand is shown once per manufacturer; strengths, forms, packs and DRAP registrations remain visible as separate presentations.| Brand | Manufacturer | Registered presentations |
|---|---|---|
| No brands match these filters. | ||
Official price changes for Ceftolozane + Tazobactam
2 official price changes across 2 tracked presentations (records from 22 Aug 2023); median change +10.4%; largest +10.4% (Zerbaxa 1 g + 0.5 g)
Each bar shows how many packs had an official DRAP price change in that month (amber: increase, teal: decrease). The figure above a bar is the median change. Hover or tap a bar for detail; the table below lists the largest changes.
| Brand | Pack | Effective | Old to new | Change |
|---|---|---|---|---|
| Zerbaxa 1 g + 0.5 g | 10's | 4 Aug 2025 | PKR 153,566.00 to 169,475.13 | +10.4% |
| Zerbaxa 1 g + 0.5 g | 1's | 4 Aug 2025 | PKR 15,356.00 to 16,946.85 | +10.4% |
Medicine information
Cite this record
Molecule record · ATC J01DIRecords change over time. Please cite the access date so readers can locate the version you used.